Jinghuaweikang capsule alleviates Helicobacter pylori-infected gastric mucosal inflammation and drug resistance by regulating intestinal microbiota and MAPK pathway
JWC preserves microbial diversity and promotes a beneficial compositional shift, mitigates the risk of antibiotic resistance, modulates the MAPK signaling pathway, and alleviates gastric mucosal inflammation in mice infected with <i>H. pylori</i>.
Authors
- Guanghui Cui (ORCID: https://orcid.org/0000-0002-1260-7198)
- Xiao-Fen Jia
- Zongming Shi
- Yao Yang (ORCID: https://orcid.org/0009-0000-5585-1804)
- Hui Ye (ORCID: https://orcid.org/0000-0001-7607-627X)
- Qiuyue Huang (ORCID: https://orcid.org/0000-0002-7354-627X)
- Xuezhi Zhang (ORCID: https://orcid.org/0000-0002-4564-7989)
- Miaomiao Lin (ORCID: https://orcid.org/0009-0007-6449-3923)
Institutions
- Peking University (CN)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.3389/fcimb.2025.1628594
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00